Alx Oncology Holdings (ALXO) Shares Issued (2020 - 2026)
Alx Oncology Holdings recorded quarterly Shares Issued of $11000.0 in Q1 2026, down 99.16% quarter-over-quarter from $1.3 million in Q4 2025, and down 97.04% year-over-year from $372000.0 in Q1 2025.
Alx Oncology Holdings' Shares Issued history runs 7 years deep, the most recent figure standing at $11000.0 for Q1 2026.
- In Q1 2026, Shares Issued fell 97.04% year-over-year to $11000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 95.09% YoY), while the FY2025 annual figure was $1.7 million, down 94.31% from the prior year.
- Shares Issued came in at $11000.0 for Q1 2026 at Alx Oncology Holdings, down from $1.3 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $28.0 million in Q4 2024 to a low of -$2.7 million in Q2 2024.
- A 5-year average of $2.3 million and a median of $185000.0 in 2022 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued slumped 98.61% in 2022 and soared 15050.81% in 2024, its largest moves.
- Alx Oncology Holdings' Shares Issued stood at $34000.0 in 2022, then soared by 444.12% to $185000.0 in 2023, then jumped by 15050.81% to $28.0 million in 2024, then slumped by 95.3% to $1.3 million in 2025, then plunged by 99.16% to $11000.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $11000.0, $1.3 million, and $357000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | -357,000.00 |
| Jun 30, 2025 | -357,000.00 |
| Mar 31, 2025 | 372,000.00 |
| Mar 31, 2025 | 372,000.00 |
| Dec 31, 2024 | 28.03 Mn |
| Dec 31, 2024 | 28.03 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | -2.72 Mn |
| Jun 30, 2024 | -2.72 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | 185,000.00 |
| Dec 31, 2023 | 185,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | -38,000.00 |
| Sep 30, 2022 | -38,000.00 |
| Jun 30, 2022 | 155,000.00 |
| Jun 30, 2022 | 155,000.00 |
| Mar 31, 2022 | 185,000.00 |
| Mar 31, 2022 | 185,000.00 |
| Dec 31, 2021 | 2.45 Mn |
| Dec 31, 2021 | 2.45 Mn |
| Sep 30, 2021 | -1.38 Mn |
| Sep 30, 2021 | -1.38 Mn |
| Jun 30, 2021 | 701,000.00 |
| Jun 30, 2021 | 701,000.00 |
| Mar 31, 2021 | 778,000.00 |
| Mar 31, 2021 | 778,000.00 |
| Dec 31, 2020 | 367.96 Mn |
| Dec 31, 2020 | 367.96 Mn |